| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE HYDROCHLORIDE | 169 |
| 1 | SACUBITRIL AND VALSARTAN | 135 |
| 2 | ALBUTEROL SULFATE | 132 |
| 3 | ERGOCALCIFEROL | 93 |
| 4 | ADALIMUMAB | 87 |
| 5 | ORAL SEMAGLUTIDE | 79 |
| 6 | ACETAMINOPHEN | 76 |
| 7 | TOFACITINIB | 76 |
| 8 | GABAPENTIN | 74 |
| 9 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 73 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERGOCALCIFEROL | 93 | 0.0031 |
| 1 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 16 | 0.0031 |
| 2 | CLINDAMYCIN PHOSPHATE | 12 | 0.0022 |
| 3 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 26 | 0.0021 |
| 4 | NIRAPARIB | 45 | 0.0020 |
| 5 | DEUTETRABENAZINE | 11 | 0.0014 |
| 6 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | 73 | 0.0013 |
| 7 | FREMANEZUMAB-VFRM | 14 | 0.0012 |
| 8 | SACUBITRIL AND VALSARTAN | 135 | 0.0012 |
| 9 | HUMAN IMMUNOGLOBULIN G | 23 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 196 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 179 |
| 2 | Benzodiazepine [EPC] | 171 |
| 3 | Corticosteroid [EPC] | 158 |
| 4 | GLP-1 Receptor Agonist [EPC] | 110 |
| 5 | Atypical Antipsychotic [EPC] | 107 |
| 6 | Opioid Agonist [EPC] | 107 |
| 7 | Provitamin D2 Compound [EPC] | 93 |
| 8 | Kinase Inhibitor [EPC] | 92 |
| 9 | Proton Pump Inhibitor [EPC] | 83 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 24 | 0.0349 |
| 1 | Provitamin D2 Compound [EPC] | 93 | 0.0031 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 3 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 4 | Opioid Antagonist [EPC] | 2 | 0.0021 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 6 | 0.0018 |
| 6 | Sodium Channel Blocker [EPC] | 3 | 0.0018 |
| 7 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 8 | Interleukin-17A Antagonist [EPC] | 58 | 0.0016 |
| 9 | alpha-Hydroxy Acid [EPC] | 3 | 0.0014 |